Company Participants Thank you, Mike, and thank you everybody for joining us this morning. I look forward to giving you a positive update on our activities for the past quarter and recent weeks. As those of you whoÂ've been with us for a while have noticed, weÂ've changed the timing to hopefully better serve our shareholders to have our quarterly calls in the morning part of the open in our press releases in the evening prior. EsoGuard is an esophageal DNA test that uses next-generation sequencing to detect ...